Literature DB >> 21394892

Bereaved parental evaluation of the quality of a palliative care program in Lebanon.

Rima Saad1, Huda Abu-Saad Huijer, Samar Noureddine, Samar Muwakkit, Raya Saab, Miguel R Abboud.   

Abstract

BACKGROUND: Palliative care (PC) is important in Pediatric Oncology as more than 20% of children with cancer still die despite modern treatment. As a significant number of children reside in countries with limited resources; more research in PC is needed there. This study aimed at evaluating the quality of care provided to children with cancer at the Children's Cancer Center of Lebanon (CCCL) during their last month of life as perceived by the bereaved parents. PROCEDURE: Between 2002 and 2007, 76 children with cancer treated at CCCL succumbed to their disease. Twenty-nine of the bereaved parents were interviewed at home about the symptoms and suffering experienced by their children during the last month of life, communication with the healthcare team, quality of care delivered, and recommendations for improving care.
RESULTS: Fatigue, anorexia, and pain were the most prevalent symptoms and edema was the most distressing. The overall communication with the healthcare team and the overall quality of care delivered was rated as "very good" to "excellent" by 86.2% and 93.1% of the participants, respectively. Parents suggested improving the organization of care, the communication, and the availability of human and material resources.
CONCLUSIONS: This study is the first conducted in Lebanon to evaluate the quality of pediatric palliative care (PPC). The parents' experiences in our country were similar to those described in other countries, religions, and cultures. Significant strengths and weaknesses in the management of the dying children, from the parents' perspective, were uncovered and recommendations for improving practice were made.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21394892     DOI: 10.1002/pbc.23082

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

Review 1.  Palliative Care as a Standard of Care in Pediatric Oncology.

Authors:  Meaghann S Weaver; Katherine E Heinze; Katherine P Kelly; Lori Wiener; Robert L Casey; Cynthia J Bell; Joanne Wolfe; Amy M Garee; Anne Watson; Pamela S Hinds
Journal:  Pediatr Blood Cancer       Date:  2015-12       Impact factor: 3.167

Review 2.  Challenges and opportunities to advance pediatric neuro-oncology care in the developing world.

Authors:  Michael H Chan; Frederick Boop; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2015-06-04       Impact factor: 1.475

Review 3.  Establishing psychosocial palliative care standards for children and adolescents with cancer and their families: An integrative review.

Authors:  Meaghann S Weaver; Katherine E Heinze; Cynthia J Bell; Lori Wiener; Amy M Garee; Katherine P Kelly; Robert L Casey; Anne Watson; Pamela S Hinds
Journal:  Palliat Med       Date:  2015-04-28       Impact factor: 4.762

Review 4.  Informational Support in Pediatric Oncology: Review of the Challenges Among Arab Families.

Authors:  Naïma Otmani; Mohammed Khattab
Journal:  J Cancer Educ       Date:  2018-08       Impact factor: 2.037

Review 5.  Palliative care for children with cancer.

Authors:  Elisha Waldman; Joanne Wolfe
Journal:  Nat Rev Clin Oncol       Date:  2013-01-22       Impact factor: 66.675

6.  Parental expectations of support from healthcare providers during pediatric life-threatening illness: A secondary, qualitative analysis.

Authors:  Kim Mooney-Doyle; Maiara Rodrigues Dos Santos; Regina Szylit; Janet A Deatrick
Journal:  J Pediatr Nurs       Date:  2017-06-29       Impact factor: 2.145

7.  A mixed-methods systematic review and meta-analysis of barriers and facilitators to paediatric symptom management at end of life.

Authors:  Katie Greenfield; Simone Holley; Daniel E Schoth; Emily Harrop; Richard F Howard; Julie Bayliss; Lynda Brook; Satbir S Jassal; Margaret Johnson; Ian Wong; Christina Liossi
Journal:  Palliat Med       Date:  2020-03-31       Impact factor: 4.762

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.